Case Report
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2926-2931
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2926
Portal vein embolization for closure of marked arterioportal shunt of hepatocellular carcinoma to enable radioembolization: A case report
Xiang-Dong Wang, Nai-Jian Ge, Ye-Fa Yang
Xiang-Dong Wang, Nai-Jian Ge, Ye-Fa Yang, Department of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
Author contributions: Wang XD composed and drafted the paper; Ge NJ revised and edited the draft; Yang YF conceptualized, designed, revised, and edited the draft.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrolment. Approval for publishing the study data was obtained from the patient.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ye-Fa Yang, MD, Chief Doctor, Professor, Department of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, No. 700 Moyu North Road, Shanghai 200438, China. decentofni@163.com
Received: August 17, 2023
Peer-review started: August 17, 2023
First decision: October 17, 2023
Revised: October 24, 2023
Accepted: December 4, 2023
Article in press: December 4, 2023
Published online: December 27, 2023
Processing time: 132 Days and 0.1 Hours
Core Tip

Core Tip: Marked arterioportal shunt (APS) can be a contraindication for transarterial radioembolization (TARE) because of the risk of radiation-induced liver toxicity or pneumonitis. In this case report, portal vein embolization was performed, for the first time, to close the APS outlet in a patient with advanced hepatocellular carcinoma. Single photon emission computed tomography revealed a low intrahepatic shunt and hepatopulmonary shunt, and TARE was performed successfully.